Mechanisms of Epigenetic Regulation of Leukemia Onset and Progression, Adv Immunol, vol.117, pp.1-38, 2013. ,
DOI : 10.1016/B978-0-12-410524-9.00001-3
Acute myeloid leukaemia in adults, The Lancet, vol.381, issue.9865, pp.484-495, 2013. ,
DOI : 10.1016/S0140-6736(12)61727-9
Gene expression profiling in acute myeloid leukaemia, The Netherlands Journal of Medicine, vol.69, pp.167-176, 2011. ,
Current treatment of acute myeloid leukemia, Current Opinion in Oncology, vol.24, issue.6, pp.711-719, 2012. ,
DOI : 10.1097/CCO.0b013e328358f62d
Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse, Journal of Clinical Oncology, vol.23, issue.9, pp.1969-1978, 2005. ,
DOI : 10.1200/JCO.2005.06.027
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia, New England Journal of Medicine, vol.366, issue.12, pp.1079-1089, 2012. ,
DOI : 10.1056/NEJMoa1112304
Age and acute myeloid leukemia, Blood, vol.107, issue.9, pp.3481-3485, 2006. ,
DOI : 10.1182/blood-2005-09-3724
Treatment of Acute Lymphoblastic Leukemia, New England Journal of Medicine, vol.354, issue.2, pp.166-178, 2006. ,
DOI : 10.1056/NEJMra052603
Translation of the Philadelphia chromosome into therapy for CML, Blood, vol.112, issue.13, pp.4808-4817, 2008. ,
DOI : 10.1182/blood-2008-07-077958
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia, New England Journal of Medicine, vol.355, issue.23, pp.2408-2417, 2006. ,
DOI : 10.1056/NEJMoa062867
Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli, Leukemia, vol.98, issue.6, pp.1034-1041, 2005. ,
DOI : 10.1038/sj.leu.2403724
Hematological cancer in 2011: New therapeutic targets and treatment strategies, Nature Reviews Clinical Oncology, vol.29, issue.2, pp.72-74, 2012. ,
DOI : 10.1038/nrclinonc.2011.212
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial, The Lancet, vol.370, issue.9583, pp.230-239, 2007. ,
DOI : 10.1016/S0140-6736(07)61125-8
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia, Journal of Clinical Oncology, vol.23, issue.18, pp.4079-4088, 2005. ,
DOI : 10.1200/JCO.2005.12.051
The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells., Proceedings of the National Academy of Sciences, vol.91, issue.11, pp.4940-4944, 1994. ,
DOI : 10.1073/pnas.91.11.4940
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor, Science, vol.264, issue.5161, pp.965-968, 1994. ,
DOI : 10.1126/science.8178155
Interleukin 15: biology and relevance to human disease, Blood, vol.97, issue.1, pp.14-32, 2001. ,
DOI : 10.1182/blood.V97.1.14
Interleukin-15 biology and its therapeutic implications in cancer, Trends in Pharmacological Sciences, vol.33, issue.1, pp.35-41, 2012. ,
DOI : 10.1016/j.tips.2011.09.004
Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides, Proceedings of the National Academy of Sciences, vol.94, issue.26, pp.14444-14449, 1997. ,
DOI : 10.1073/pnas.94.26.14444
The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling, BioEssays, vol.6, issue.4, pp.362-377, 2006. ,
DOI : 10.1002/bies.20380
Interleukin 15 as a promising candidate for tumor immunotherapy, Cytokine & Growth Factor Reviews, vol.22, issue.2, pp.99-108, 2011. ,
DOI : 10.1016/j.cytogfr.2011.04.001
Crystal Structure of the Interleukin-15{middle dot}Interleukin-15 Receptor ?? Complex: INSIGHTS INTO TRANS AND CIS PRESENTATION, Journal of Biological Chemistry, vol.282, issue.51, pp.37191-37204, 2007. ,
DOI : 10.1074/jbc.M706150200
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15., Proceedings of the National Academy of Sciences, vol.92, issue.19, pp.8705-8709, 1995. ,
DOI : 10.1073/pnas.92.19.8705
New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway, Molecular and Cellular Biology, vol.20, issue.19, pp.7109-7120, 2000. ,
DOI : 10.1128/MCB.20.19.7109-7120.2000
Evidence for the Involvement of LCK and MAP Kinase (ERK-1) in the Signal Transduction Mechanism of Interleukin-15, Biochemical and Biophysical Research Communications, vol.232, issue.3, pp.754-758, 1997. ,
DOI : 10.1006/bbrc.1997.6367
Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation, Cell, vol.81, issue.2, pp.223-231, 1995. ,
DOI : 10.1016/0092-8674(95)90332-1
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design, Nature Reviews Immunology, vol.153, issue.8, pp.595-601, 2006. ,
DOI : 10.1038/nri1901
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15, Blood, vol.124, issue.7, pp.1081-1088, 2014. ,
DOI : 10.1182/blood-2014-02-556837
Combined IL-15/IL-15R?? Immunotherapy Maximizes IL-15 Activity In Vivo, The Journal of Immunology, vol.177, issue.9, pp.6072-6080, 2006. ,
DOI : 10.4049/jimmunol.177.9.6072
IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway, The Journal of Immunology, vol.182, issue.11 ,
DOI : 10.4049/jimmunol.0801792
URL : https://hal.archives-ouvertes.fr/pasteur-01375190
Interleukin-15 enhances proliferation and chemokine secretion of human follicular dendritic cells, Immunology, vol.8, issue.4, pp.536-544, 2010. ,
DOI : 10.1111/j.1365-2567.2010.03252.x
IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation, The Journal of Immunology, vol.167, issue.3, pp.1179-1187, 2001. ,
DOI : 10.4049/jimmunol.167.3.1179
Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responsesin vivo, European Journal of Immunology, vol.34, issue.1, pp.66-73, 2004. ,
DOI : 10.1002/eji.200324567
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes, Immunity, vol.14, issue.2, pp.161-167, 2002. ,
DOI : 10.1016/S1074-7613(01)00093-0
Interleukin-15 Enhances Proteasomal Degradation of Bid in Normal Lymphocytes: Implications for Large Granular Lymphocyte Leukemias, Cancer Research, vol.69, issue.9, pp.3986-3994, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-3735
Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor, J Immunol, vol.163, issue.7, pp.4064-4072, 1999. ,
Human T Cell Lymphotropic Virus Type I Tax Activates IL-15R?? Gene Expression Through an NF-??B Site, The Journal of Immunology, vol.166, issue.4, pp.2602-2609, 2001. ,
DOI : 10.4049/jimmunol.166.4.2602
Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins, Proceedings of the National Academy of Sciences, vol.94, issue.25, pp.13897-13902, 1997. ,
DOI : 10.1073/pnas.94.25.13897
Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines, Blood, vol.102, issue.12, pp.4130-4136, 2003. ,
DOI : 10.1182/blood-2003-04-1043
Current concepts: large granular lymphocyte leukemia, Blood Reviews, vol.13, issue.4, pp.230-240, 1999. ,
DOI : 10.1054/blre.1999.0118
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes, Blood, vol.89, issue.1, pp.201-211, 1997. ,
Increased serum soluble IL-15R?? levels in T-cell large granular lymphocyte leukemia, Blood, vol.119, issue.1, pp.137-143, 2012. ,
DOI : 10.1182/blood-2011-04-346759
Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer, Clinical Cancer Research, vol.20, issue.8, pp.2044-2050, 2014. ,
DOI : 10.1158/1078-0432.CCR-12-3603
Mutations in Large Granular Lymphocytic Leukemia, New England Journal of Medicine, vol.366, issue.20, pp.1905-1913, 2012. ,
DOI : 10.1056/NEJMoa1114885
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia, Blood, vol.120, issue.15, pp.3048-3057, 2012. ,
DOI : 10.1182/blood-2012-06-435297
Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation, Cancer Cell, vol.22, issue.5, pp.645-655, 2012. ,
DOI : 10.1016/j.ccr.2012.09.009
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human, Journal of Clinical Investigation, vol.121, issue.4, pp.1456-1470, 2011. ,
DOI : 10.1172/JCI43242DS1
Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells, Blood, vol.87, issue.7, pp.2632-2640, 1996. ,
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders, Blood, vol.87, issue.8, pp.3327-3336, 1996. ,
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes, Blood, vol.89, issue.1, pp.201-211, 1997. ,
Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies, Blood, vol.73, issue.7, pp.1968-1972, 1989. ,
Cytokine response profiles of human myeloid factor-dependent leukemia cell lines, Leukemia, vol.11, issue.5, pp.701-708, 1997. ,
DOI : 10.1038/sj.leu.2400633
Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor ??/??, International Journal of Cancer, vol.89, issue.2, pp.189-195, 1998. ,
DOI : 10.1002/(SICI)1097-0215(19981005)78:2<189::AID-IJC12>3.0.CO;2-6
High Interleukin-15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia With Involvement of the CNS, Journal of Clinical Oncology, vol.25, issue.30, pp.4813-4820, 2007. ,
DOI : 10.1200/JCO.2007.11.8166
Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia, Blood, vol.123, issue.20, pp.3116-3127, 2014. ,
DOI : 10.1182/blood-2013-05-499970
Perforin- and granulysin-mediated cytotoxicity and interleukin 15 play roles in neurocognitive impairment in patients with acute lymphoblastic leukaemia, Medical Hypotheses, vol.83, issue.1, pp.122-126, 2014. ,
DOI : 10.1016/j.mehy.2014.03.024
Polymorphisms in Interleukin-15 Gene on Chromosome 4q31.2 Are Associated with Psoriasis Vulgaris in Chinese Population, Journal of Investigative Dermatology, vol.127, issue.11, pp.2544-2551, 2007. ,
DOI : 10.1038/sj.jid.5700896
Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia, JAMA, vol.301, issue.4, pp.393-403, 2009. ,
DOI : 10.1001/jama.2009.7
The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia, PLoS ONE, vol.5, issue.10, p.13626, 2010. ,
DOI : 10.1371/journal.pone.0013626.s002
Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukaemia in Egypt, Leuk Lymphoma, 2014. ,
Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia, Blood, vol.93, issue.5, pp.1534-1539, 1999. ,
Altered natural killer cell differentiation in CD34+ progenitors from Chronic Myeloid Leukemia patients, Oncogene, vol.19, issue.23, pp.2758-2766, 2000. ,
DOI : 10.1038/sj.onc.1203584
A requirement for NF-kappa B activation in Bcr-Abl-mediated??transformation, Genes & Development, vol.12, issue.7, pp.968-981, 1998. ,
DOI : 10.1101/gad.12.7.968
The NF-??B binding site is essential for transcriptional activation of the IL-15 gene, Immunogenetics, vol.48, issue.1, pp.1-7, 1998. ,
DOI : 10.1007/s002510050393
Differential Effects on CLL Cell Survival Exerted by Different Microenvironmental Elements, Curr Top Microbiol Immunol, vol.294, pp.135-145, 2005. ,
DOI : 10.1007/3-540-29933-5_8
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1??, Blood, vol.106, issue.3, pp.1012-1020, 2005. ,
DOI : 10.1182/blood-2004-03-0889
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1, Blood, vol.96, issue.8, pp.2655-2663, 2000. ,
The IL-2 receptor complex: expression and function on normal and leukemic B cells, Leukemia, vol.9, issue.9, pp.1425-1431, 1995. ,
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders, Blood, vol.87, issue.8, pp.3327-3335, 1996. ,
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells, Science, vol.298, issue.5601, pp.2199-2202, 2002. ,
DOI : 10.1126/science.1076071
Follicular Dendritic Cells Produce IL-15 That Enhances Germinal Center B Cell Proliferation in Membrane-Bound Form, The Journal of Immunology, vol.173, issue.11, pp.6676-6683, 2004. ,
DOI : 10.4049/jimmunol.173.11.6676
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways, Blood, vol.111, issue.2, pp.517-524, 2008. ,
DOI : 10.1182/blood-2007-04-087882
Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling, Leukemia, vol.91, issue.1, pp.139-148, 2012. ,
DOI : 10.1016/j.cell.2010.07.044
URL : https://hal.archives-ouvertes.fr/inserm-00869028
A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.7, pp.717-722, 2008. ,
DOI : 10.2174/187152008785914752
Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia, Blood, vol.121, issue.3, pp.476-484, 2013. ,
DOI : 10.1182/blood-2012-08-450585
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression, Journal of Clinical Investigation, vol.107, issue.3, pp.351-362, 2001. ,
DOI : 10.1172/JCI9940
Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice, Blood, vol.117, issue.6, pp.1888-1898, 2011. ,
DOI : 10.1182/blood-2010-10-310599
IFN-?? promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment, Blood, vol.103, issue.3, pp.980-987, 2004. ,
DOI : 10.1182/blood-2003-03-0981
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells, Journal of Clinical Investigation, vol.111, issue.5, pp.639-647, 2003. ,
DOI : 10.1172/JCI200316398
Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia, Seminars in Hematology, vol.40, issue.1, pp.87-96, 2003. ,
DOI : 10.1016/S0037-1963(03)70046-8
Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway, International Immunology, vol.20, issue.7, pp.801-810, 2008. ,
DOI : 10.1093/intimm/dxn038
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15, Blood, vol.108, issue.4, pp.1313-1319, 2006. ,
DOI : 10.1182/blood-2005-11-011320
Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression, Experimental Hematology, vol.38, issue.5, pp.351-362, 2010. ,
DOI : 10.1016/j.exphem.2010.02.006
Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study, Bone Marrow Transplantation, vol.90, issue.6, pp.1038-1046, 2010. ,
DOI : 10.1016/j.autrev.2005.04.017
Recombinant Human IL-15 Trans-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy, The Journal of Immunology, vol.191, issue.7, pp.3634-3640, 2013. ,
DOI : 10.4049/jimmunol.1300187
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer, Journal of Clinical Oncology, vol.33, issue.1, pp.74-82, 2015. ,
DOI : 10.1200/JCO.2014.57.3329
Targets and Therapy downloaded from https ,